Loading...
Treatment After First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small-Cell Lung Cancer
Systemic treatment is the basic treatment approach to advanced-stage non-small-cell lung cancer (NSCLC), and chemotherapy and targeted treatments are commonly employed in these patients. Recently, positive results achieved with immunotherapy have led to a growing number of treatment options and prol...
Na minha lista:
| Udgivet i: | Turk Thorac J |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Turkish Thoracic Society
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5783084/ https://ncbi.nlm.nih.gov/pubmed/29404164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/TurkThoracJ.2017.16042 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|